Current capacities for neuroimaging in the differential diagnosis of cognitive impairments
https://doi.org/10.14412/2074-2711-2012-2509
Abstract
The authors give the results of their investigations of and the generalized data available in the literature on the significance of neuroimaging techniques in the diagnosis of cognitive impairment of different origins. Special attention is given to the importance of applying current diagnostic methods for functional neuroimaging both in early and advanced dementias: in Alzheimer's disease, vascular dementia, and mixed pathology.
About the Authors
A. Y. Emelin
Department of Nervous System Disease, S.M. Kirov Military Medical Academy, Ministry of Defense of the Russian Federation, Saint Petersburg
Russian Federation
Russian Federation
М. М. Odinak
Department of Nervous System Disease, S.M. Kirov Military Medical Academy, Ministry of Defense of the Russian Federation, Saint Petersburg
Russian Federation
Russian Federation
V. Yu. Lobzin
Department of Nervous System Disease, S.M. Kirov Military Medical Academy, Ministry of Defense of the Russian Federation, Saint Petersburg
Russian Federation
Russian Federation
S. V. Vorobyev
Department of Nervous System Disease, S.M. Kirov Military Medical Academy, Ministry of Defense of the Russian Federation, Saint Petersburg
Russian Federation
Russian Federation
V. N. Kiselev
Department of Nervous System Disease, S.M. Kirov Military Medical Academy, Ministry of Defense of the Russian Federation, Saint Petersburg
Russian Federation
Russian Federation
References
1. <div><p>Ferri C.P., Prince M., Brayne C. et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112–17.</p><p>Van Straaten E.C., Scheltens P., Barkhof F. MRI and CT in the diagnosis of vascular dementia. J Neurol Sci 2004;226(1/2):9–12.</p><p>Hsu Y., Du A., Schuff N. et al. Magnetic resonance imaging and magnetic resonance spectroscopy in dementias. J Geriatr Psychiatry Neurol 2001;14(3):145–66.</p><p>Одинак М.М., Емелин А.Ю., Лобзин В.Ю. Нарушение когнитивных функций при цереброваскулярной патологии. СПб.: ВМедА, 2006;158 с.</p><p>Яхно Н.Н., Левин О.С., Дамулин И.В. Сопоставление клинических и МРТ-данных при дисциркуляторной энцефалопатии. Сообщение 2: когнитивные нарушения. Неврол журн 2001;6(3):16–8.</p><p>Яхно Н.Н., Захаров В.В. Когнитивные и эмоционально-аффективные нарушения при дисциркуляторной энцефалопатии. РМЖ 2002;10(12/13):531–51.</p><p>Debette S., Beiser A., DeCarli C. et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke 2010;41(4):600–6.</p><p>Дамулин И.В. Сосудистая деменция. Неврол журн 1999;3(4):4–11.</p><p>Van Dijk E.J., Prins N.D., Vrooman H.A. et al. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences. Rotterdam Scan Study. Stroke 2008;39(5):2712–9.</p><p>Schmidt R., Petrovic K., Ropele S. et al. Progression of leukoaraiosis and cognition. Stroke 2007;38(9):2619–25.</p><p>Одинак М.М. Позитронная эмиссионная томография. В кн.: Неврология: нац. рук-во. Под ред. Е.И. Гусева М.: ГЭОТАР-Медиа, 2009;167–71.</p><p>Dubois B., Feldman H.H., Jacova C. et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria. Lancet Neurol 2007;6(8):734–46.</p><p>Alexander G.F., Chen K., Pietrini P. et al. Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer`s disease treatment studies. Am J Psychiatry 2002;159(5):738–45.</p><p>O'Brien J.T. Role of imaging techniques in the diagnosis of dementia. Br J Radiol 2007;80(2):S71–S77.</p><p>Емелин А.Ю., Одинак М.М., Труфанов Г.Е. и др. Возможности позитронной эмиссионной компьютерной томографии в дифференциальной диагностике деменций. Вестн Рос ВМе¬дА 2010;4(32):46–51.</p><p>O'Brien J.L., O'Keefe K.M., LaViolette P.S. et al. Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology 2010;74(24):1969–76.</p><p>Kwan L., Reed B., Eberling J. et al. Effects of subcortical cerebral infarction on cortical glucose metabolism and cognitive function. Arch Neurol 1999;56(7):809–14.</p><p>Mintun M.A., Larossa G.N., Sheline Y.I. et al. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 2006;67:446–52.</p><p>Ikonomovic M.D., Klunk W.E., Abrahamson E.E. et al. Post-mortem correlates of in vivo PiB–PET amyloid imaging in a typical case of Alzheimer’s disease. Brain 2008;131:1630–45.</p><p>Bonte F.J., Weiner M.F., Bigio E.H. et al. SPECT imaging in dementias. J Nucl Med 2001;42(7):1131–3.</p><p>Pimlott S.L., Ebmeier K.P. SPECT imaging in dementia. Br J Radiol 2007;80(2):S153–S159.</p><p>Camargo E.E. Brain SPECT in neurology and psychiatry. J Nucl Med 2001;42(4):611–23.</p><p>Capizzano A.A., Schuff N., Amend D.L. et al. Subcortical Ischemic Vascular Dementia: Assessment with Quantitative MR Imaging and 1H MR Spectroscopy. Am J Neuroradiol 2000;21:621–30.</p><p>Zhang Y., Schuff N., Jahng G.-H. et al. Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology 2007;68:13–9.</p><p>Емелин А.Ю., Фокин В.А., Лобзин В.Ю. и др. Трактография как новый метод изучения патогенеза и дифференциальной диагностики деменций. Вестн Рос ВмедА (прил.) 2010;4(32):26–7.</p><p>Rombouts S.A., van Swieten J.C., Pijnenburg Y.A.L. et al. Loss of frontal fMRI activation in early frontotemporal dementia compared to early AD / S.A.R.B. Rombouts. Neurology 2003;60(12):1904–8.</p><p>Galvin J.E., Price J.L., Yan Z. Resting bold fMRI differentiates dementia with Lewy bodies vs Alzheimer disease. Neurology 2011;76(21):1797–803.</p></div><br />
Review
For citations:
Emelin A.Y., Odinak М.М., Lobzin V.Yu., Vorobyev S.V., Kiselev V.N. Current capacities for neuroimaging in the differential diagnosis of cognitive impairments. Neurology, Neuropsychiatry, Psychosomatics. 2012;4(2S):51-55. (In Russ.) https://doi.org/10.14412/2074-2711-2012-2509
Views: 957
Email this article 